Reda G Yousef

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Molecularly Imprinted

Molecular Dynamics Simulations

Epidermal Growth Factor Receptor

Virtual Reality

Top Venues

Life (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Ibrahim H Eissa, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Eslam B Elkaeed, Ahmed M Metwaly
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study. Life (Basel, Switzerland) 13 (1) (2023)
Eslam B Elkaeed, Reda G Yousef, Mohamed M Khalifa, Albaraa Ibrahim, Ahmed B M Mehany, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Wagdy M Eldehna, Ahmed M Metwaly, Ibrahim H Eissa, Mohamed Ayman El-Zahabi
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules (Basel, Switzerland) 27 (19) (2022)
Eslam B Elkaeed, Reda G Yousef, Hazem Elkady, Ibraheem M M Gobaara, Bshra Ali A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects. Molecules (Basel, Switzerland) 27 (14) (2022)
Reda G Yousef, Hazem Elkady, Eslam B Elkaeed, Ibraheem M M Gobaara, Hanan A Al-Ghulikah, Dalal Z Husein, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
( E )- N -(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules (Basel, Switzerland) 27 (22) (2022)
Eslam B Elkaeed, Reda G Yousef, Hazem Elkady, Aisha A Alsfouk, Dalal Z Husein, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
New Anticancer Theobromine Derivative Targeting EGFR WT and EGFR T790M : Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies. Molecules (Basel, Switzerland) 27 (18) (2022)